- Home
- WST vs ZBH Comparison
WST vs ZBH Comparison
Compare WST & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- ZBH
- Stock Information
- Founded
- WST 1923
- ZBH 1927
- Country
- WST United States
- ZBH United States
- Employees
- WST N/A
- ZBH N/A
- Industry
- WST Medical/Dental Instruments
- ZBH Industrial Specialties
- Sector
- WST Health Care
- ZBH Health Care
- Exchange
- WST Nasdaq
- ZBH Nasdaq
- Market Cap
- WST 24.4B
- ZBH 21.8B
- IPO Year
- WST N/A
- ZBH N/A
- Fundamental
- Price
- WST $223.73
- ZBH $107.70
- Analyst Decision
- WST Strong Buy
- ZBH Buy
- Analyst Count
- WST 5
- ZBH 22
- Target Price
- WST $367.50
- ZBH $124.15
- AVG Volume (30 Days)
- WST 1.7M
- ZBH 1.9M
- Earning Date
- WST 04-24-2025
- ZBH 05-01-2025
- Dividend Yield
- WST 0.38%
- ZBH 0.90%
- EPS Growth
- WST N/A
- ZBH N/A
- EPS
- WST 6.69
- ZBH 4.43
- Revenue
- WST $2,893,200,000.00
- ZBH $7,678,600,000.00
- Revenue This Year
- WST $0.93
- ZBH $3.68
- Revenue Next Year
- WST $6.68
- ZBH $4.53
- P/E Ratio
- WST $33.46
- ZBH $24.16
- Revenue Growth
- WST N/A
- ZBH 3.85
- 52 Week Low
- WST $197.01
- ZBH $97.69
- 52 Week High
- WST $400.88
- ZBH $133.90
- Technical
- Relative Strength Index (RSI)
- WST 34.95
- ZBH 54.52
- Support Level
- WST $222.26
- ZBH $103.44
- Resistance Level
- WST $234.36
- ZBH $111.95
- Average True Range (ATR)
- WST 7.86
- ZBH 2.86
- MACD
- WST 3.96
- ZBH 0.38
- Stochastic Oscillator
- WST 52.31
- ZBH 55.40
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.